Yahoo
Tokyo - Delayed Quote JPY

Alfresa Holdings Corporation (2784.T)

2,442.50 -26.50 (-1.07%)
As of 1:40:53 PM GMT+9. Market Open.
Chart Range Bar
Loading chart for 2784.T
  • Previous Close 2,469.00
  • Open 2,476.50
  • Bid 2,441.50 x --
  • Ask 2,443.00 x --
  • Day's Range 2,440.00 - 2,489.50
  • 52 Week Range 2,106.50 - 2,685.50
  • Volume 98,600
  • Avg. Volume 468,051
  • Market Cap (intraday) 428.439B
  • Beta (5Y Monthly) -0.16
  • PE Ratio (TTM) 11.31
  • EPS (TTM) 215.87
  • Earnings Date Nov 9, 2026
  • Forward Dividend & Yield 72.00 (2.92%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est 2,293.33

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. The company operates through Wholesale of Prescription Drugs and Related Products, Wholesale of Self-Medication Products, Manufacturing of Pharmaceuticals and Related Products, and Pharmacy and Related Businesses segments. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products; and engages in insurance agency, real estate management, and sales of daily necessities and consumables activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Chiyoda, Japan.

www.alfresa.com

12,525

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2784.T
3.40%
Nikkei 225 (^N225)
26.20%

1-Year Return

2784.T
15.49%
Nikkei 225 (^N225)
21.21%

3-Year Return

2784.T
7.76%
Nikkei 225 (^N225)
98.84%

5-Year Return

2784.T
76.72%
Nikkei 225 (^N225)
115.20%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 788.96B
Earnings 2.48B
Profit Margin 0.31%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
200B
400B
600B
800B
0.5%
1.0%
1.5%
2.0%

Analyst Insights

View More

Analyst Price Targets

2,180.00 Low
2,293.33 Average
2,442.50 Current
2,500.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.25%

  • Return on Assets (ttm)

    1.45%

  • Return on Equity (ttm)

    8.17%

  • Revenue (ttm)

    3.13T

  • Net Income Avi to Common (ttm)

    39.22B

  • Diluted EPS (ttm)

    215.87

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    192.07B

  • Total Debt/Equity (mrq)

    6.17%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: